|
|
 |
|
Viewing report
|
|
|
|
Ovarian Cancer Therapeutics - Global Strategic Business Report
Global Industry Analysts, Inc., Feb 2006, Pages: 248
This report analyzes the worldwide markets for Ovarian Cancer Therapeutics in Millions of US$. The major product segments analyzed are Localized Ovarian Cancer Therapeutics, Metastatic Ovarian Cancer Therapeutics, and Refractory Ovarian Cancer Therapeutics. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2010. The report profiles 42 companies including many key and niche players worldwide such as Alza Corporation, Amgen, Inc., Bristol-Myers Squibb, Cell Therapeutics, Inc., Genentech Inc., GlaxoSmithkline, Immunogen, Inc., Ivax, OSI Pharmaceuticals, and Raven Biotechnologies, Inc.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on 'Enquire before buying'
Customers who bought this item also bought
Breast Cancer Therapeutics - Global Strategic Business Report
Colorectal Cancer (CRC) Therapeutics - Global Strategic Business Report
Antidepressants - Global Strategic Business Report
Respiratory Drugs - Global Strategic Business Report
Antivirals - Global Strategic Business Report
Asthma Therapeutics - Global Strategic Business Report
Lipid Regulators - Global Strategic Business Report
Bladder Cancer Therapeutics - Global Strategic Business Report
Prostate Cancer Therapeutics - Global Strategic Business Report
Lymphoma Therapeutics - Global Strategic Business Report
|
|
|
|
